Top Markets
#1 Black Phoenix Black Phoenix +736.57%
#2 Islamic Coin Islamic Coin +146.17%
#3 THORChain THORChain +26.71%
#4 MiL.k Alliance MiL.k Alliance +26.65%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.17%
#6 THORChain Yield THORChain Yield +20.24%
#7 Bless Bless +19.93%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.36%
#9 TENDIES TENDIES +14.32%
#10 Tutorial Tutorial +12.78%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Healthcare
Earnings for Aerovate Therapeutics, Inc. (AVTE)
Earnings in Jun 2026 TTM: $-188.80M
According to Aerovate Therapeutics, Inc. latest financial reports the company's current earnings are $-188.80M. In 2023 the company made an earning of $-75.47M, a decrease compared to its 2022 earnings that were of $-51.49M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Aerovate Therapeutics, Inc. from 2019 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-188.80M 171.37%
2024 $-69.57M -7.81%
2023 $-75.47M 46.57%
2022 $-51.49M 124.24%
2021 $-22.96M 138.89%
2020 $-9.61M 188.62%
2019 $-3.33M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -2,893.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -1,133.17%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 1,535.05%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 2,027.20%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH